Work

Randomized Trial of a Novel CMV Vaccine (CMVPepVax) after Allogeneic HCT: Elevated CMV-Specific Immune Response, Reduction in Chronic GvHD and CMV Reactivation Only in Vaccine Arm Patients

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.183.183

Authors: Ryotaro Nakamura, Corinna La Rosa, Jeff Longmate, Margaret O'Donnell, Ji-Lian Cai, Len Farol, Amandeep Salhotra, David S Snyder, Jennifer Drake, Cynthia Slape, James Merson, John A Zaia, Stephen J. Forman, Don J. Diamond

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute, Pfizer (United States)

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2581781057

FWCI: 0.225

Cites:

Cited by: 1

Related to: 10